Abstract
Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 920-923 |
| Number of pages | 4 |
| Journal | Oncoscience |
| Volume | 2 |
| DOIs | |
| Publication status | Published - 2015 |
Keywords
- Cancer Research
- Genes
- Non-coding RNA
- Oncology
- Prostrate cancer
- miRNA
